MedPath

Effectiveness of a Combined Pressure and Silicone Intervention for Hypertrophic Scar Treatment

Not Applicable
Conditions
Rehabilitation
Cicatrix, Hypertrophic
Interventions
Device: compression
Device: occlusion
Registration Number
NCT03628495
Lead Sponsor
The Hong Kong Polytechnic University
Brief Summary

Pressure therapy (PT) and silicone therapy are recommended as first-line non-invasive treatments HS, yet the effectiveness of the combination of these two treatments through an RCT trial has not been established yet. This study aims to examine the effectiveness of the combination of adequate pressure therapy and silicone gel sheeting implemented by Smart Scar Care Pad (SSCP) + Smart Pressure Monitored Suit (SPMS) versus conventional Pressure Garment (PG in the management of severe HS in adult. It is hypothesized that the combination of adequate pressure therapy and silicone gel sheeting will demonstrate its superiority in improving scar parameters than conventional pressure garment therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
72
Inclusion Criteria
  • The Vancouver Scar Scale (VSS) will be used to screen candidates for the study.10 Isolated scars with a total score of 4 or higher and the score of each item equal to or greater than 1 will be included.
  • The scar size should also reach 2*2 cm2 or above to allow adequate area for assessment tool attachement.
  • Consenting adult's age between 19 to 60 years old who is able to provide written consent, cooperative, and good compliance with treatment.
Exclusion Criteria
  • the HS area have an open wound or infection;
  • the HS have been treated with steroid injections or other intervention (such as traditional Chinese medicine or laser therapy) prior to the study;
  • the patients have a medical condition that might affect wound healing (e.g., diabetes mellitus or another serious medical problem);
  • the patients with comorbidities that might affect their compliance to treatment: such as severe scar contracture at adjacent area that might be scheduled for reconstructive surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SSCP + SPMSocclusion-
SSCP + SPMScompression-
PGcompression-
Primary Outcome Measures
NameTimeMethod
Change from baseline HS thickness at 6 monthsat baseline, one and six month after treatment

HS thickness measured by the Diagnostic Ultrasound System

Secondary Outcome Measures
NameTimeMethod
Change from baseline HS pliability at 6 monthsat baseline, one and six month after treatment

HS pliability measured by the DermaLab Combo elasticity measurement

Change from baseline HS hydration at 6 monthsat baseline, one and six month after treatment

HS hydration measured by the DermaLab Combo hydration measurement

Change from baseline HS color at 6 monthsat baseline, one and six month after treatment

HS color measured by the DermaLab Combo Color measurement

Itchinessat baseline, one and six month after treatment

HS Itchiness measured by the Numerical rating scale

QoLat baseline, one and six month after treatment

SF-36 will be used to measure the Quality of Life.

© Copyright 2025. All Rights Reserved by MedPath